Simultaneous determination of acyclovir, ganciclovir, and (R)‐9‐[4‐hydroxy‐2‐(hydroxymethyl)butyl]guanine in human plasma using high‐performance liquid chromatography
- 7 April 2009
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 23 (8) , 822-827
Abstract
Acyclovir, ganciclovir and (R)‐9‐[4‐hydroxy‐2‐(hydroxymethyl)butyl]guanine are active in vitro against the Epstein–Barr virus (EBV) but their in vivo anti‐EBV activity is not well understood. We developed a novel, sensitive high‐performance liquid chromatography assay with ultraviolet detection for measuring acyclovir, ganciclovir and (R)‐9‐[4‐hydroxy‐2‐(hydroxymethyl)butyl]guanine in human plasma to identify quantitative relationships between in vitro anti‐EBV activity and therapeutic response. Characteristics of the assay include a low plasma volume (200 µL), perchloric acid protein precipitation, use of penciclovir as the internal standard, run times less than 8 min and a 50 ng/mL lower limit of quantification. The within‐ and between‐assay variability is 0.7–4.8 and 1.0–7.9%, respectively. Accuracy for all three drugs ranges from 89.5 to 106.4% for four quality controls (50, 100, 1000 and 10,000 ng/mL). This assay supports pharmacokinetic and pharmacodynamic studies of candidate anti‐EBV drugs in children and adults with EBV infections. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Adolescents Are More Likely to Develop Posttransplant Lymphoproliferative Disorder After Primary Epstein-Barr Virus Infection Than Younger Renal Transplant RecipientsTransplantation, 2007
- Case–control study of risk factors for the development of post‐transplant lymphoproliferative disease in a pediatric heart transplant cohort*Pediatric Transplantation, 2006
- EBV-associated mononucleosis leads to long-term global deficit in T-cell responsiveness to IL-15Blood, 2006
- Increasing Incidence of Severe Epstein-Barr Virus-Related Infectious Mononucleosis: Surveillance StudyJournal of Clinical Microbiology, 2006
- A Randomized Trial of Ganciclovir versus Ganciclovir Plus Immune Globulin for Prophylaxis Against Epstein-Barr Virus Related Posttransplant Lymphoproliferative DisorderTransplantation, 2006
- Ganciclovir and Acyclovir Reduce the Risk of Post‐Transplant Lymphoproliferative Disorder in Renal Transplant RecipientsAmerican Journal of Transplantation, 2005
- A simple and simultaneous determination of acyclovir and ganciclovir in human plasma by high‐performance liquid chromatographyBiomedical Chromatography, 2003
- Acyclovir for Treatment of Infectious Mononucleosis: A Meta-analysisScandinavian Journal of Infectious Diseases, 1999
- A simple high performance liquid chromatography (HPLC) assay for aciclovir and ganciclovir in serumJournal of Antimicrobial Chemotherapy, 1996
- POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANTATIONTransplantation, 1996